UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000025436 |
|---|---|
| Receipt number | R000029258 |
| Scientific Title | Phase II multicenter trial of platinum-cetuximab combined with docetaxel or with 5FU for Japanese patients with recurrent/metastatic squamous cell carcinoma of the head and neck. |
| Date of disclosure of the study information | 2017/03/01 |
| Last modified on | 2019/07/01 09:52:31 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2016/12/27 17:59:21 | ||
| 2 | Update | 2017/04/14 06:39:47 | Anticipated trial start date |
|
| 3 | Update | 2017/06/28 13:22:51 | Anticipated trial start date |
|
| 4 | Update | 2017/09/19 19:17:09 | UMIN ID1 |
|
| 5 | Update | 2017/12/08 09:11:41 | Recruitment status |
|
| 6 | Update | 2018/04/19 14:20:49 | Institutions |
|
| 7 | Update | 2018/05/08 17:31:02 | Institutions |
|
| 8 | Update | 2018/07/13 15:31:24 | Anticipated trial start date |
|
| 9 | Update | 2019/07/01 09:50:35 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel Institutions |
|
| 10 | Update | 2019/07/01 09:52:31 | Date of IRB Last follow-up date |
